Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Completed · Phase 2/Phase 3

Conditions studied: Alzheimer Disease

In brief

The purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer's disease (AD).

Key facts

Study ID

NCT00277810

Run by

Pfizer

People needed

250

Starts

2006-03-01

Expected to finish

2008-06-01

Last updated by the study team

2020-07-07

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of probable Alzheimer's disease
• Current use of cholinesterase inhibitor
• Able to give signed and dated informed consent and lives with appropriate caregiver at home or in community dwelling with caregiver accompanying patient to all visits and visiting patient at least daily for duration of the study

You may not qualify if…

• Significant neurological disease other than AD
• Diagnosis of major depression
• History of stroke or other heart disease

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Costa Mesa, California, United States
• Study site — Fresno, California, United States
• Study site — La Jolla, California, United States
• Study site — Orange, California, United States
• Study site — Delray Beach, Florida, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Fort Myers, Florida, United States
• Study site — Hallandale, Florida, United States
• Study site — Hialeah, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Miami Beach, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Sarasota, Florida, United States
• Study site — South Miami, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — St Louis, Missouri, United States
• Study site — Long Branch, New Jersey, United States
• Study site — Manchester Twp., New Jersey, United States
• Study site — Albany, New York, United States
• Study site — Cedarhurst, New York, United States
• Study site — Staten Island, New York, United States
• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.